Cargando…

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic. The continued spread of SARS-CoV-2 increases the probability of influenza/SARS-CoV-2 coinfection, which may result in severe disease. In this study, we examine the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Achdout, Hagit, Vitner, Einat. B., Politi, Boaz, Melamed, Sharon, Yahalom-Ronen, Yfat, Tamir, Hadas, Erez, Noam, Avraham, Roy, Weiss, Shay, Cherry, Lilach, Bar-Haim, Erez, Makdasi, Efi, Gur, David, Aftalion, Moshe, Chitlaru, Theodor, Vagima, Yaron, Paran, Nir, Israely, Tomer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492774/ https://www.ncbi.nlm.nih.gov/pubmed/34611155 http://dx.doi.org/10.1038/s41467-021-26113-1

Ejemplares similares

Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus
por: Vitner, Einat B., et al.
Publicado: (2021)

Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2
por: Erez, Noam, et al.
Publicado: (2023)

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
por: Tamir, Hadas, et al.
Publicado: (2022)

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
por: Bar-On, Liat, et al.
Publicado: (2022)

Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 Infection
por: Chitlaru, Theodor, et al.
Publicado: (2021)

A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
por: Noy-Porat, Tal, et al.
Publicado: (2020)

VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2023)

Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope
por: Makdasi, Efi, et al.
Publicado: (2021)

Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities
por: Ben-Shmuel, Amir, et al.
Publicado: (2020)

Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
por: Katzman, Chaja, et al.
Publicado: (2021)

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments
por: Vagima, Yaron, et al.
Publicado: (2020)

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization
por: Noy-Porat, Tal, et al.
Publicado: (2023)

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2020)

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2022)

Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination Efficacy
por: Melamed, Sharon, et al.
Publicado: (2021)

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice
por: Gutman, Hila, et al.
Publicado: (2022)

rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits
por: Rosner, Amir, et al.
Publicado: (2022)

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs
por: Madar-Balakirski, Noa, et al.
Publicado: (2022)

Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2
por: Falach, Reut, et al.
Publicado: (2021)

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
por: Israeli, Ma’ayan, et al.
Publicado: (2022)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Rosenfeld, Ronit, et al.
Publicado: (2021)

Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism
por: Strobelt, Romano, et al.
Publicado: (2022)

Parsing the role of NSP1 in SARS-CoV-2 infection
por: Fisher, Tal, et al.
Publicado: (2022)

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants
por: Makdasi, Efi, et al.
Publicado: (2021)

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
por: Chaouat, Abigael Eva, et al.
Publicado: (2021)

Parsing the role of NSP1 in SARS-CoV-2 infection
por: Fisher, Tal, et al.
Publicado: (2022)

Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens
por: Barlev-Gross, Moria, et al.
Publicado: (2021)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Discriminative Identification of SARS-CoV-2 Variants Based on Mass-Spectrometry Analysis
por: Feldberg, Liron, et al.
Publicado: (2023)

Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
por: Noy-Porat, Tal, et al.
Publicado: (2021)

Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
por: Vitner, Einat B, et al.
Publicado: (2021)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains
por: Israely, Tomer, et al.
Publicado: (2019)

HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State
por: Domovitz, Tom, et al.
Publicado: (2022)

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2022)

Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system
por: Avraham, Roy, et al.
Publicado: (2023)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Development of an immunofluorescence assay for detection of SARS-CoV-2
por: Atiya-Nasagi, Yafit, et al.
Publicado: (2022)

Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue Explants
por: Bui, Christine H T, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qfs6npoijckns8d6ou37ntolb0